2013 annual financial data
Processa Pharmaceuticals 2013 Operating margin
Direct answer
Operating margin was -947.68%.
Operating income was -2,961,320 USD and net income was -3,068,701 USD.
Operating cash flow was -2,538,769 USD.
Get free Processa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 312,480 USD
- Operating income
- -2,961,320 USD
- Net income
- -3,068,701 USD
- Operating cash flow
- -2,538,769 USD